RPS-BLAST 2.2.26 [Sep-21-2011]

Database: CDD.v3.10 
           44,354 sequences; 10,937,602 total letters

Searching..................................................done

Query= psy15360
         (109 letters)



>gnl|CDD|238368 cd00717, URO-D, Uroporphyrinogen decarboxylase (URO-D) is a dimeric
           cytosolic enzyme that decarboxylates the four acetate
           side chains of uroporphyrinogen III (uro-III) to create
           coproporphyrinogen III, without requiring any prosthetic
           groups or cofactors. This reaction is located at the
           branching point of the tetrapyrrole biosynthetic
           pathway, leading to the biosynthesis of heme,
           chlorophyll or bacteriochlorophyll. URO-D deficiency is
           responsible for the human genetic diseases familial
           porphyria cutanea tarda (fPCT) and hepatoerythropoietic
           porphyria (HEP).
          Length = 335

 Score =  148 bits (375), Expect = 5e-45
 Identities = 49/106 (46%), Positives = 66/106 (62%), Gaps = 2/106 (1%)

Query: 3   NDVPMTIFAKGAHYALEELNQTKYDIVGIDWTIEPSLARSII-KNKTLQGNLDPCALYAS 61
             VP+ +FAKGA   LE+L Q   D+VG+DW ++   AR  +     LQGNLDP  LYA 
Sbjct: 229 PGVPVILFAKGAGGLLEDLAQLGADVVGLDWRVDLDEARKRLGPKVALQGNLDPALLYAP 288

Query: 62  KEKLRKIGTQMAKEFG-KSRYIANLGHGIYPDMDPEHVQVLIDAIH 106
           KE + K   ++ K FG    +I NLGHGI PD  PE+V+ L++A+H
Sbjct: 289 KEAIEKEVKRILKAFGGAPGHIFNLGHGILPDTPPENVKALVEAVH 334


>gnl|CDD|233423 TIGR01464, hemE, uroporphyrinogen decarboxylase.  This model
           represents uroporphyrinogen decarboxylase (HemE), which
           converts uroporphyrinogen III to coproporphyrinogen III.
           This step takes the pathway toward protoporphyrin IX, a
           common precursor of both heme and chlorophyll, rather
           than toward precorrin 2 and its products [Biosynthesis
           of cofactors, prosthetic groups, and carriers, Heme,
           porphyrin, and cobalamin].
          Length = 338

 Score =  135 bits (343), Expect = 3e-40
 Identities = 49/106 (46%), Positives = 70/106 (66%), Gaps = 2/106 (1%)

Query: 3   NDVPMTIFAKGAHYALEELNQTKYDIVGIDWTIEPSLARSII-KNKTLQGNLDPCALYAS 61
             VP+ +FAKGA + LEEL +T  D+VG+DW+++   AR  +     +QGNLDP  LYA 
Sbjct: 232 PGVPVILFAKGAGHLLEELAETGADVVGLDWSVDLKEARKRVGDGVAIQGNLDPAVLYAP 291

Query: 62  KEKLRKIGTQMAKEF-GKSRYIANLGHGIYPDMDPEHVQVLIDAIH 106
           +E L +   ++ + F GKS YI NLGHGI PD  PE+V+ L++ +H
Sbjct: 292 EEALEEKVERILEAFGGKSGYIFNLGHGILPDTPPENVKALVEYVH 337


>gnl|CDD|234644 PRK00115, hemE, uroporphyrinogen decarboxylase; Validated.
          Length = 346

 Score =  125 bits (316), Expect = 3e-36
 Identities = 44/106 (41%), Positives = 65/106 (61%), Gaps = 1/106 (0%)

Query: 3   NDVPMTIFAKGAHYALEELNQTKYDIVGIDWTIEPSLARSII-KNKTLQGNLDPCALYAS 61
            DVP+ +F KGA   LE + +T  D+VG+DWT++ + AR  +   K LQGNLDP  L A 
Sbjct: 238 PDVPVILFGKGAGELLEAMAETGADVVGLDWTVDLAEARRRVGDKKALQGNLDPAVLLAP 297

Query: 62  KEKLRKIGTQMAKEFGKSRYIANLGHGIYPDMDPEHVQVLIDAIHD 107
            E + +    +    G   +I NLGHGI P+  PE+V+ L++A+H+
Sbjct: 298 PEAIEEEVRAILDGGGGPGHIFNLGHGILPETPPENVKALVEAVHE 343


>gnl|CDD|216366 pfam01208, URO-D, Uroporphyrinogen decarboxylase (URO-D). 
          Length = 338

 Score =  114 bits (289), Expect = 2e-32
 Identities = 36/104 (34%), Positives = 62/104 (59%), Gaps = 2/104 (1%)

Query: 6   PMTIFAKGAH-YALEELNQTKYDIVGIDWTIEPSLARSIIKNKTLQGNLDPCALYASKEK 64
           P+ +   G     LE++ +T  D++ +DWT++ + A+ I+ +  LQGNLDP  L  + E+
Sbjct: 234 PVILHICGNGTPILEDMAETGADVISLDWTVDLAEAKRIVGDVALQGNLDPALLLGTPEE 293

Query: 65  LRKIGTQM-AKEFGKSRYIANLGHGIYPDMDPEHVQVLIDAIHD 107
           +     ++     G   +I NLGHGI PD  PE+V+ L++A+H+
Sbjct: 294 IEAEVKEILEAGDGGPGHIFNLGHGIPPDTPPENVKALVEAVHE 337


>gnl|CDD|215237 PLN02433, PLN02433, uroporphyrinogen decarboxylase.
          Length = 345

 Score =  105 bits (264), Expect = 1e-28
 Identities = 37/105 (35%), Positives = 59/105 (56%), Gaps = 1/105 (0%)

Query: 4   DVPMTIFAKGAHYALEELNQTKYDIVGIDWTIEPSLARSIIKNK-TLQGNLDPCALYASK 62
           DVP+ ++A G+   LE L  T  D++G+DWT++ + AR  + +   +QGN+DP  L+ SK
Sbjct: 232 DVPLILYANGSGGLLERLAGTGVDVIGLDWTVDMADARRRLGSDVAVQGNVDPAVLFGSK 291

Query: 63  EKLRKIGTQMAKEFGKSRYIANLGHGIYPDMDPEHVQVLIDAIHD 107
           E + K    + K+ G   +I NLGHG+      E+V    D   +
Sbjct: 292 EAIEKEVRDVVKKAGPQGHILNLGHGVLVGTPEENVAHFFDVARE 336


>gnl|CDD|223484 COG0407, HemE, Uroporphyrinogen-III decarboxylase [Coenzyme
           metabolism].
          Length = 352

 Score =  104 bits (261), Expect = 3e-28
 Identities = 43/107 (40%), Positives = 70/107 (65%), Gaps = 2/107 (1%)

Query: 2   NNDVPMTIFAKGAHYALEELNQTKYDIVGIDWTIEPSLARSIIKNK-TLQGNLDPCALYA 60
              VP+  F KGA + LE++ +T +D++G+DW ++   A+  + +K  LQGNLDP  LYA
Sbjct: 240 KGGVPVIHFCKGAGHLLEDMAKTGFDVLGVDWRVDLKEAKKRLGDKVALQGNLDPALLYA 299

Query: 61  SKEKLRKIGTQMAKEFG-KSRYIANLGHGIYPDMDPEHVQVLIDAIH 106
             E +++   ++ ++ G  S YI NLGHGI P+  PE+V+ L++A+H
Sbjct: 300 PPEAIKEEVKRILEDGGDGSGYIFNLGHGILPETPPENVKALVEAVH 346


>gnl|CDD|238261 cd00465, URO-D_CIMS_like, The URO-D_CIMS_like protein superfamily
           includes bacterial and eukaryotic uroporphyrinogen
           decarboxylases (URO-D), coenzyme M methyltransferases
           and other putative bacterial methyltransferases, as well
           as cobalamine (B12) independent methionine synthases.
           Despite their sequence similarities, members of this
           family have clearly different functions.
           Uroporphyrinogen decarboxylase (URO-D) decarboxylates
           the four acetate side chains of uroporphyrinogen III
           (uro-III) to create coproporphyrinogen III, an important
           branching point of the tetrapyrrole biosynthetic
           pathway. The methyltransferases represented here are
           important for ability of methanogenic organisms to use
           other compounds than carbon dioxide for reduction to
           methane, and methionine synthases transfer a methyl
           group from a folate cofactor to L-homocysteine in a
           reaction requiring zinc.
          Length = 306

 Score = 76.8 bits (189), Expect = 4e-18
 Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 6/110 (5%)

Query: 2   NNDVPMTIFAKG-AHYALEELNQTKYDIVGIDWTI-EPSLARSIIKNK-TLQGNLDPCAL 58
             +VP+   +   A   LEE+ Q   D++  D T+ EP  A   +  K TL G +DP  L
Sbjct: 197 AGEVPIVHHSCYDAADLLEEMIQLGVDVISFDMTVNEPKEAIEKVGEKKTLVGGVDPGYL 256

Query: 59  YASKEKLRKIGTQMAKEFGKSRYIANLGHGIYPDMD--PEHVQVLIDAIH 106
            A+ E+      ++ +  G   YI N   G+ PD D  PEH++ ++  + 
Sbjct: 257 PATDEECIAKVEELVERLGP-HYIINPDCGLGPDSDYKPEHLRAVVQLVD 305


>gnl|CDD|239548 cd03465, URO-D_like, The URO-D _like protein superfamily includes
           bacterial and eukaryotic uroporphyrinogen decarboxylases
           (URO-D), coenzyme M methyltransferases and other
           putative bacterial methyltransferases. Uroporphyrinogen
           decarboxylase (URO-D) decarboxylates the four acetate
           side chains of uroporphyrinogen III (uro-III) to create
           coproporphyrinogen III, an important branching point of
           the tetrapyrrole biosynthetic pathway. The
           methyltransferases represented here are important for
           ability of methanogenic organisms to use other compounds
           than carbon dioxide for reduction to methane.
          Length = 330

 Score = 60.8 bits (148), Expect = 3e-12
 Identities = 30/111 (27%), Positives = 54/111 (48%), Gaps = 6/111 (5%)

Query: 3   NDVPMTIFAKGAHYA-LEELNQTKYDIVGIDWTIEPSLARSIIKNK-TLQGNLDPCA-LY 59
              P+     G     LE +     D+  ID T++ + A+  + +K  L GNLDP   L 
Sbjct: 220 LGGPVIHHNCGDTAPILELMADLGADVFSIDVTVDLAEAKKKVGDKACLMGNLDPIDVLL 279

Query: 60  A-SKEKLRKIGTQMAKEFGK--SRYIANLGHGIYPDMDPEHVQVLIDAIHD 107
             S E++++   ++ ++  K    YI + G  I PD   E+++ +IDA+ +
Sbjct: 280 NGSPEEIKEEVKELLEKLLKGGGGYILSSGCEIPPDTPIENIKAMIDAVRE 330


>gnl|CDD|237973 PRK15488, PRK15488, thiosulfate reductase PhsA; Provisional.
          Length = 759

 Score = 31.2 bits (71), Expect = 0.075
 Identities = 8/22 (36%), Positives = 14/22 (63%)

Query: 69  GTQMAKEFGKSRYIANLGHGIY 90
           G ++ ++   S+YI N GH +Y
Sbjct: 187 GGKLKRDLANSKYIINFGHNLY 208


>gnl|CDD|239156 cd02755, MopB_Thiosulfate-R-like, The MopB_Thiosulfate-R-like CD
           contains thiosulfate-, sulfur-, and
           polysulfide-reductases, and other related proteins.
           Thiosulfate reductase catalyzes the cleavage of
           sulfur-sulfur bonds in thiosulfate. Polysulfide
           reductase is a membrane-bound enzyme that catalyzes the
           reduction of polysulfide using either hydrogen or
           formate as the electron donor. Members of the
           MopB_Thiosulfate-R-like CD belong to the
           molybdopterin_binding (MopB) superfamily of proteins.
          Length = 454

 Score = 30.7 bits (70), Expect = 0.095
 Identities = 10/46 (21%), Positives = 20/46 (43%)

Query: 60  ASKEKLRKIGTQMAKEFGKSRYIANLGHGIYPDMDPEHVQVLIDAI 105
           A K  +   G ++  +F  +RYI   G  +   +     + L+ A+
Sbjct: 138 AWKLVIDSFGGEVNPDFENARYIILFGRNLAEAIIVVDARRLMKAL 183


>gnl|CDD|239423 cd03307, Mta_CmuA_like, MtaA_CmuA_like family. MtaA/CmuA, also
           MtsA, or methyltransferase 2 (MT2) MT2-A and MT2-M
           isozymes, are methylcobamide:Coenzyme M
           methyltransferases, which play a role in metabolic
           pathways of methane formation from various substrates,
           such as methylated amines and methanol. Coenzyme M,
           2-mercaptoethylsulfonate or CoM, is methylated during
           methanogenesis in a reaction catalyzed by three
           proteins. A methyltransferase methylates the corrinoid
           cofactor, which is bound to a second polypeptide, a
           corrinoid protein. The methylated corrinoid protein then
           serves as a substrate for MT2-A and related enzymes,
           which methylate CoM.
          Length = 326

 Score = 29.6 bits (67), Expect = 0.25
 Identities = 11/39 (28%), Positives = 21/39 (53%), Gaps = 1/39 (2%)

Query: 18  LEELNQTKYDIVGIDWTIEPSLARSIIKNKT-LQGNLDP 55
           LE + Q  +D + +D  ++   A+ I+  +  L GN+ P
Sbjct: 237 LEYIAQCGFDGISVDEKVDVKTAKEIVGGRAALIGNVSP 275


>gnl|CDD|163057 TIGR02881, spore_V_K, stage V sporulation protein K.  Members of
           this protein family are the stage V sporulation protein
           K (SpoVK), a close homolog of the Rubisco expression
           protein CbbX (TIGR02880) and a members of the ATPase
           family associated with various cellular activities
           (pfam00004). Members are strictly limited to bacterial
           endospore-forming species, but are not universal in this
           group and are missing from the Clostridium group
           [Cellular processes, Sporulation and germination].
          Length = 261

 Score = 28.1 bits (63), Expect = 0.79
 Identities = 15/56 (26%), Positives = 30/56 (53%), Gaps = 4/56 (7%)

Query: 32  DWTIEP--SLARSIIKNKTLQGNLDPCALYASKEKLRKIGTQMAKEFGKSRYIANL 85
           D+T+E    +A  ++K +  +  L   A +  +E L K+    ++EF  +RY+ N+
Sbjct: 177 DYTVEELMEIAERMVKEREYK--LTEEAKWKLREHLYKVDQLSSREFSNARYVRNI 230


>gnl|CDD|234315 TIGR03695, menH_SHCHC,
           2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate
           synthase.  This protein catalyzes the formation of
           SHCHC, or (1 R,6
           R)-2-succinyl-6-hydroxy-2,
           4-cyclohexadiene-1-carboxylate, by elmination of
           pyruvate from
           2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-
           carboxylate (SEPHCHC). Note that SHCHC synthase activity
           previously was attributed to MenD, which in fact is
           SEPHCHC synthase [Biosynthesis of cofactors, prosthetic
           groups, and carriers, Menaquinone and ubiquinone].
          Length = 252

 Score = 27.9 bits (63), Expect = 0.95
 Identities = 11/30 (36%), Positives = 14/30 (46%), Gaps = 2/30 (6%)

Query: 63  EKLRKIGTQMAKEFGKSRY--IANLGHGIY 90
           EK  +I  +M K         IAN GH I+
Sbjct: 207 EKFVQIAKEMQKLIPNLTLVIIANAGHNIH 236


>gnl|CDD|218819 pfam05942, PaREP1, Archaeal PaREP1/PaREP8 family.  This family
           consists of several archaeal PaREP1 and PaREP8 proteins
           the function of this family is unknown.
          Length = 114

 Score = 26.8 bits (60), Expect = 1.8
 Identities = 12/69 (17%), Positives = 23/69 (33%), Gaps = 13/69 (18%)

Query: 52  NLDPCALYASKEKLRKIGT------QMAKEFGK--SRY--IANLGH---GIYPDMDPEHV 98
           N    A  A  +             ++ +E G+       +A   H      P++D   V
Sbjct: 44  NRLKLAEKARGKGRWSHRLLMKAVAKLLEEGGEEVVDLWSLALDLHVYQFYDPELDLSDV 103

Query: 99  QVLIDAIHD 107
           +   +A+ D
Sbjct: 104 EDREEAVKD 112


>gnl|CDD|199208 cd08964, L-asparaginase_II, Type II (periplasmic) bacterial
           L-asparaginase.  Asparaginases (amidohydrolases, E.C.
           3.5.1.1) are enzymes that catalyze the hydrolysis of
           asparagine to aspartic acid and ammonia. In bacteria,
           there are two classes of amidohydrolases. This model
           represents type II L-asparaginases, which tend to be
           highly specific for asparagine and localized to the
           periplasm. They are potent antileukemic agents and have
           been used in the treatment of acute lymphoblastic
           leukemia (ALL), but not without severe side effects.
           Tumor cells appear to have a heightened dependence on
           exogenous L-aspartate, and depleting their surroundings
           of L-aspartate may starve cancerous ALL cells. Type II
           L-asparaginase acts as a tetramer, which is actually a
           dimer of two tightly bound dimers. A conserved threonine
           residue is thought to supply the nucleophile
           hydroxy-group that attacks the amide bond. Many
           bacterial L-asparaginases have both L-asparagine and
           L-glutamine hydrolysis activities, to a different
           degree, and some of them are annotated as
           asparaginase/glutaminase.
          Length = 319

 Score = 26.3 bits (59), Expect = 3.3
 Identities = 8/28 (28%), Positives = 13/28 (46%), Gaps = 3/28 (10%)

Query: 82  IANLGHGIYPDMDPEHVQVLIDAIHDAL 109
           ++NL      DM P     L   +++AL
Sbjct: 50  VSNLPS---SDMTPADWLALAARVNEAL 74


>gnl|CDD|225106 COG2195, PepD, Di- and tripeptidases [Amino acid transport and
           metabolism].
          Length = 414

 Score = 26.1 bits (58), Expect = 4.3
 Identities = 12/57 (21%), Positives = 19/57 (33%)

Query: 53  LDPCALYASKEKLRKIGTQMAKEFGKSRYIANLGHGIYPDMDPEHVQVLIDAIHDAL 109
            D     A K+ ++ +  +MA   GK           YP    +    L+D    A 
Sbjct: 290 FDNLLFRARKDSMKDVVEEMAASLGKLAGAELEVKDSYPGWKIKPDSPLVDLAKKAY 346


>gnl|CDD|132753 cd07068, NR_LBD_ER_like, The ligand binding domain of estrogen
           receptor and estrogen receptor-related receptors.  The
           ligand binding domain of estrogen receptor (ER) and
           estrogen receptor-related receptors (ERRs): Estrogen
           receptors are a group of receptors which are activated
           by the hormone estrogen. Estrogen regulates many
           physiological processes including reproduction, bone
           integrity, cardiovascular health, and behavior. The main
           mechanism of action of the estrogen receptor is as a
           transcription factor by binding to the estrogen response
           element of target genes upon activation by estrogen and
           then recruiting coactivator proteins which are
           responsible for the transcription of target genes.
           Additionally some ERs may associate with other membrane
           proteins and can be rapidly activated by exposure of
           cells to estrogen.  ERRs are closely related to the
           estrogen receptor (ER) family. But, it lacks the ability
           to bind estrogen.  ERRs can interfere with the classic
           ER-mediated estrogen signaling pathway, positively or
           negatively. ERRs  share target genes, co-regulators and
           promoters with the estrogen receptor (ER) family. Like
           other members of the nuclear receptor (NR) superfamily
           of ligand-activated transcription factors, ER and ERRs
           have  a central well conserved DNA binding domain (DBD),
           a variable N-terminal domain, a non-conserved hinge and
           a C-terminal ligand binding domain (LBD).
          Length = 221

 Score = 25.6 bits (57), Expect = 5.1
 Identities = 16/47 (34%), Positives = 23/47 (48%), Gaps = 1/47 (2%)

Query: 63  EKLRKIGTQMAKEFGKSRYIANLGHGIYPDMDPEHVQVLIDAIHDAL 109
            + R++G Q  +E+   + I      +    D E VQ L DAI DAL
Sbjct: 118 RRFRELGLQR-EEYVCLKAIILANSDVRHLEDREAVQQLRDAILDAL 163


>gnl|CDD|189007 cd09600, M1_APN_1, Peptidase M1 family containing Aminopeptidase N.
            This family contains aminopeptidase N (APN; CD13;
           Alanyl aminopeptidase; EC 3.4.11.2), a Type II integral
           membrane protease belonging to the M1 gluzincin family.
           It includes bacterial-type alanyl aminopeptidases as
           well as PfA-M1 aminopeptidase (Plasmodium
           falciparum-type). APN consists of a small N-terminal
           cytoplasmic domain, a single transmembrane domain and a
           large extracellular ectodomain that contains the active
           site. It preferentially cleaves neutral amino acids from
           the N-terminus of oligopeptides and, in higher
           eukaryotes, is present in a variety of human tissues and
           cell types (leukocyte, fibroblast, endothelial and
           epithelial cells). APN expression is dysregulated in
           inflammatory diseases such as chronic pain, rheumatoid
           arthritis, multiple sclerosis, systemic sclerosis,
           systemic lupus erythematosus,
           polymyositis/dermatomyosytis and pulmonary sarcoidosis,
           and is enhanced in tumor cells such as melanoma, renal,
           prostate, pancreas, colon, gastric and thyroid cancers.
           It is predominantly expressed on stem cells and on cells
           of the granulocytic and monocytic lineages at distinct
           stages of differentiation, thus considered a marker of
           differentiation. Thus, APN inhibition may lead to the
           development of anti-cancer and anti-inflammatory drugs.
           APNs are also present in many pathogenic bacteria and
           represent potential drug targets, Some APNs have been
           used commercially, such as one from Lactococcus lactis
           used in the food industry. APN also serves as a receptor
           for coronaviruses, although the virus receptor
           interaction site seems to be distinct from the enzymatic
           site and aminopeptidase activity is not necessary for
           viral infection. APNs have also been extensively studied
           as putative Cry toxin receptors. Cry1 proteins are
           pore-forming toxins that bind to the midgut epithelial
           cell membrane of susceptible insect larvae, causing
           extensive damage. Several different toxins, including
           Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have
           been shown to bind to APNs; however, a direct role of
           APN in cytotoxicity has been yet to be firmly
           established.
          Length = 861

 Score = 26.1 bits (58), Expect = 5.3
 Identities = 8/28 (28%), Positives = 16/28 (57%), Gaps = 1/28 (3%)

Query: 50  QGNLDPCALYASKEKLRK-IGTQMAKEF 76
              +DP A++ ++E L K + T++  E 
Sbjct: 621 MEVIDPDAIHEAREALIKQLATELKDEL 648


>gnl|CDD|102374 PRK06434, PRK06434, cystathionine gamma-lyase; Validated.
          Length = 384

 Score = 26.0 bits (57), Expect = 5.4
 Identities = 23/85 (27%), Positives = 37/85 (43%), Gaps = 14/85 (16%)

Query: 24  TKY-----DIV-GIDWTIEPSLARS-IIKNKTLQGNLDPCALYASKEKLRKIGTQMAKEF 76
           TKY     D+V G+  T   S+  + + + KTL  N DP   Y +   L+ +G +M K  
Sbjct: 206 TKYISGHSDVVMGVAGTNNKSIFNNLVERRKTLGSNPDPIQAYLALRGLKTLGLRMEKHN 265

Query: 77  GKSRYIA-------NLGHGIYPDMD 94
                +A        + +  YPD +
Sbjct: 266 KNGMELARFLRDSKKISNVYYPDTE 290


>gnl|CDD|214873 smart00870, Asparaginase, Asparaginase, found in various plant,
           animal and bacterial cells.  Asparaginase catalyses the
           deamination of asparagine to yield aspartic acid and an
           ammonium ion, resulting in a depletion of free
           circulatory asparagine in plasma. The enzyme is
           effective in the treatment of human malignant lymphomas,
           which have a diminished capacity to produce asparagine
           synthetase: in order to survive, such cells absorb
           asparagine from blood plasma..- if Asn levels have been
           depleted by injection of asparaginase, the lymphoma
           cells die.
          Length = 323

 Score = 25.6 bits (57), Expect = 7.0
 Identities = 9/32 (28%), Positives = 15/32 (46%), Gaps = 3/32 (9%)

Query: 78  KSRYIANLGHGIYPDMDPEHVQVLIDAIHDAL 109
           +   +AN+      +M PE    L   I++AL
Sbjct: 45  EVEQVANIDS---SNMTPEDWLKLAKRINEAL 73


>gnl|CDD|216261 pfam01041, DegT_DnrJ_EryC1, DegT/DnrJ/EryC1/StrS aminotransferase
           family.  The members of this family are probably all
           pyridoxal-phosphate-dependent aminotransferase enzymes
           with a variety of molecular functions. The family
           includes StsA, StsC and StsS. The aminotransferase
           activity was demonstrated for purified StsC protein as
           the L-glutamine:scyllo-inosose aminotransferase
           EC:2.6.1.50, which catalyzes the first amino transfer in
           the biosynthesis of the streptidine subunit of
           streptomycin.
          Length = 362

 Score = 25.3 bits (56), Expect = 7.4
 Identities = 5/18 (27%), Positives = 10/18 (55%)

Query: 88  GIYPDMDPEHVQVLIDAI 105
            +YP +  E V  + +A+
Sbjct: 344 PLYPGLTLEEVDRVAEAV 361


>gnl|CDD|223476 COG0399, WecE, Predicted pyridoxal phosphate-dependent enzyme
           apparently involved in regulation of cell wall
           biogenesis [Cell envelope biogenesis, outer membrane].
          Length = 374

 Score = 25.3 bits (56), Expect = 9.2
 Identities = 6/21 (28%), Positives = 14/21 (66%)

Query: 89  IYPDMDPEHVQVLIDAIHDAL 109
           ++P++  E V  +I+A+ + L
Sbjct: 351 LHPNLSEEDVDRVIEALKEVL 371


>gnl|CDD|221331 pfam11940, DUF3458, Domain of unknown function (DUF3458).  This
           presumed domain is functionally uncharacterized. This
           domain is found in bacteria, archaea and eukaryotes.
           This domain is typically between 402 to 419 amino acids
           in length. This domain is found associated with
           pfam01433. This domain has a conserved FSAPV sequence
           motif.
          Length = 365

 Score = 25.2 bits (56), Expect = 9.5
 Identities = 8/29 (27%), Positives = 15/29 (51%), Gaps = 1/29 (3%)

Query: 49  LQGNLDPCALYASKEKLRK-IGTQMAKEF 76
               +DP A++A++E LR  +   +  E 
Sbjct: 165 QMKVVDPDAIHAAREFLRAALAEALRDEL 193


>gnl|CDD|99856 cd06102, citrate_synt_like_2, Citrate synthase (CS) catalyzes the
           condensation of acetyl coenzyme A (AcCoA) and
           oxalacetate (OAA) to form citrate and coenzyme A (CoA),
           the first step in the oxidative citric acid cycle (TCA
           or Krebs cycle). Peroxisomal CS is involved in the
           glyoxylate cycle. This group also includes CS proteins
           which functions as a 2-methylcitrate synthase (2MCS).
           2MCS catalyzes the condensation of propionyl-CoA (PrCoA)
           and OAA to form 2-methylcitrate and CoA during
           propionate metabolism. This group contains proteins
           which functions exclusively as either a CS or a 2MCS, as
           well as those with relaxed specificity which have dual
           functions as both a CS and a 2MCS. The overall CS
           reaction is thought to proceed through three partial
           reactions and involves both closed and open
           conformational forms of the enzyme: a) the carbanion or
           equivalent is generated from AcCoA by base abstraction
           of a proton, b) the nucleophilic attack of this
           carbanion on OAA to generate citryl-CoA, and c) the
           hydrolysis of citryl-CoA to produce citrate and CoA.
           There are two types of CSs: type I CS and type II CSs.
           Type I CSs are found in eukarya, gram-positive bacteria,
           archaea, and in some gram-negative bacteria and are
           homodimers with both subunits participating in the
           active site.  Type II CSs are unique to gram-negative
           bacteria and are homohexamers of identical subunits
           (approximated as a trimer of dimers).  Some type II CSs
           are strongly and specifically inhibited by NADH through
           an allosteric mechanism. This subgroup includes both
           gram-positive and gram-negative bacteria.
          Length = 282

 Score = 24.9 bits (55), Expect = 9.6
 Identities = 9/28 (32%), Positives = 13/28 (46%), Gaps = 1/28 (3%)

Query: 82  IANLGHGIYPDMDPEHVQVLIDAIHDAL 109
           +   GH +YPD DP     L+ A+    
Sbjct: 180 LPGFGHPLYPDGDPR-AAALLAALRPLG 206


>gnl|CDD|223330 COG0252, AnsB, L-asparaginase/archaeal Glu-tRNAGln amidotransferase
           subunit D [Amino acid transport and metabolism /
           Translation, ribosomal structure and biogenesis].
          Length = 351

 Score = 24.9 bits (55), Expect = 9.6
 Identities = 9/19 (47%), Positives = 12/19 (63%)

Query: 91  PDMDPEHVQVLIDAIHDAL 109
            DM PE    L +AI++AL
Sbjct: 78  SDMTPEDWLRLAEAINEAL 96


>gnl|CDD|218969 pfam06277, EutA, Ethanolamine utilisation protein EutA.  This
           family consists of several bacterial EutA ethanolamine
           utilisation proteins. The EutA protein is thought to
           protect the lyase (EutBC) from inhibition by CNB12.
          Length = 473

 Score = 24.9 bits (55), Expect = 9.9
 Identities = 6/23 (26%), Positives = 11/23 (47%)

Query: 84  NLGHGIYPDMDPEHVQVLIDAIH 106
            LG  +   + P+   + ID+I 
Sbjct: 422 VLGQTLQALLGPKKPIICIDSIK 444


  Database: CDD.v3.10
    Posted date:  Mar 20, 2013  7:55 AM
  Number of letters in database: 10,937,602
  Number of sequences in database:  44,354
  
Lambda     K      H
   0.318    0.136    0.400 

Gapped
Lambda     K      H
   0.267   0.0824    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 5,686,940
Number of extensions: 479201
Number of successful extensions: 576
Number of sequences better than 10.0: 1
Number of HSP's gapped: 562
Number of HSP's successfully gapped: 47
Length of query: 109
Length of database: 10,937,602
Length adjustment: 74
Effective length of query: 35
Effective length of database: 7,655,406
Effective search space: 267939210
Effective search space used: 267939210
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 53 (24.0 bits)